Si-Bone Inc
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFu… Read more
Si-Bone Inc (SIBN) - Total Liabilities
Latest total liabilities as of September 2025: $62.15 Million USD
Based on the latest financial reports, Si-Bone Inc (SIBN) has total liabilities worth $62.15 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Si-Bone Inc - Total Liabilities Trend (2013–2024)
This chart illustrates how Si-Bone Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Si-Bone Inc Competitors by Total Liabilities
The table below lists competitors of Si-Bone Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pell Bio-Med Technology Co., Ltd.
TW:6949
|
Taiwan | NT$385.71 Million |
|
Jiangxi Ganneng Co Ltd
SHE:000899
|
China | CN¥13.23 Billion |
|
MorningStar Partners, L.P.
NYSE:TXO
|
USA | $639.94 Million |
|
MedCap AB (publ)
ST:MCAP
|
Sweden | Skr1.15 Billion |
|
CGN Nuclear Technology Development Co Ltd
SHE:000881
|
China | CN¥4.75 Billion |
|
Senton Energy Co. Ltd. A
SHE:001331
|
China | CN¥179.80 Million |
|
Kunshan Guoli Electronic Technology Co Ltd
SHG:688103
|
China | CN¥1.40 Billion |
|
Ur Energy Inc
NYSE MKT:URG
|
USA | $80.27 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Si-Bone Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Si-Bone Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Si-Bone Inc (2013–2024)
The table below shows the annual total liabilities of Si-Bone Inc from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $63.47 Million | +3.97% |
| 2023-12-31 | $61.05 Million | +3.04% |
| 2022-12-31 | $59.25 Million | +5.64% |
| 2021-12-31 | $56.09 Million | +4.29% |
| 2020-12-31 | $53.78 Million | -0.41% |
| 2019-12-31 | $54.00 Million | +11.74% |
| 2018-12-31 | $48.33 Million | -70.75% |
| 2017-12-31 | $165.21 Million | +11.50% |
| 2016-12-31 | $148.17 Million | +351.43% |
| 2015-12-31 | $32.82 Million | +48.56% |
| 2014-12-31 | $22.09 Million | +12.34% |
| 2013-12-31 | $19.67 Million | -- |